Opioid manufacturer agrees to $150M settlement after class-action lawsuit led by B.C. asks for $60B
CTV
British Columbia says a proposed $150-million settlement with Purdue Pharma Canada has been reached for the recovery of health-care costs related to the sale and marketing of opioid-based pain medicines.
British Columbia says a proposed $150-million settlement with Purdue Pharma Canada has been reached for the recovery of health-care costs related to the sale and marketing of opioid-based pain medicines.
Attorney General David Eby says it's the largest settlement of a governmental health care cost claim in Canadian history.
The province launched a class-action lawsuit in 2018 on behalf of all federal, provincial and territorial governments with the aim of recovering health-care costs over the ``wrongful conduct of opioid manufacturers, distributors and their consultants.''
This is a developing news story and will be updated